Early Access — free while we kick the tires
EdgarHawk

Fitzpatrick Alexander A

Chief Legal Officer

Officer
1 filing analyzed · 1 company · Latest 2025-05-22

Companies

Company Buys Sells Direction
ARS Pharmaceuticals, Inc. SPRY 0 2 Net selling

Activity

May 2025
high
Sell
102,969 shares
$1,451,513
Significance 6/10

CLO Fitzpatrick Alexander sold 102,969 shares (53.5% of holdings) at $14.10 on 2025-05-20, reducing stake to 89.6K shares

Fitzpatrick sold over half of his SPRY holdings (102,969 shares, -53.5% of pre-transaction holdings) for $1,451,512.81, leaving him with 89.6K shares post-transaction. The sale occurred at $14.10 while the stock now trades at $14.52 (current price), just -17.0% from its 52-week high of $17.49, and the stock is up 29.2% over the past 90 days. The company's fundamentals show acute losses: net income of $-33,940,000.00 against quarterly revenue of $7,973,000.00, yet the market cap stands at $1,426,060,905.72 with an inflated P/E of 181.50, suggesting a highly speculative valuation. His prior trades at this ticker (two buys in Sept 2023) both showed positive 90-day returns (+48.8%, +55.6%), indicating a pattern of well-timed prior buys in SPRY, but this sale—the first recorded disposition—occurs during a period of significant stock appreciation rather than decline.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access